(Q33873285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Thrombolytic therapy for stroke: a review with particular reference to elderly patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M Roberts

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

41-54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10733263%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002512-200016010-00004

5 November 2019

exact match

0 references

cites work

Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome After Embolic Stroke

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Early intravenous thrombolysis for acute ischemic stroke in a community-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Hypertension and its treatment in the NINDS rt-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Local intra-arterial thrombolysis in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Intra-arterial pro-urokinase in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Discharge outcome after stroke rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00004

Does arterial recanalization improve outcome in carotid territory stroke?

21 January 2018

1 reference

12 December 2020

Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction

1 reference

12 December 2020

Changes in coagulation and fibrinolytic system after local intra-arterial thrombolysis for acute ischemic stroke

1 reference

12 December 2020

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

12 December 2020

North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke

1 reference

12 December 2020

Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits

1 reference

12 December 2020

Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

1 reference

12 December 2020

Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease

1 reference

12 December 2020

Intravenous aspirin causes a paradoxical attenuation of cerebrovascular thrombolysis

1 reference

12 December 2020

Dissent: an alternative interpretation of MAST-I. Multicentre Acute Stroke Trial--Italy Group

1 reference

12 December 2020

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

1 reference

12 December 2020

Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra.

1 reference

12 December 2020

Progressive derangement of periinfarct viable tissue in ischemic stroke.

1 reference

12 December 2020

Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography.

1 reference

12 December 2020

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

1 reference

12 December 2020

Streptokinase in acute stroke: effect on reperfusion and recanalization. Australian Streptokinase Trial Study Group

1 reference

12 December 2020

Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk.

1 reference

12 December 2020

Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model

1 reference

12 December 2020

Ethical challenges in stroke research

1 reference

12 December 2020

Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic stroke

1 reference

12 December 2020

Hemorrhage after an acute ischemic stroke.MAST-I Collaborative Group.

1 reference

12 December 2020

Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome

1 reference

12 December 2020

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

1 reference

12 December 2020

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

12 December 2020

Incidence of space-occupying brain edema following systemic thrombolysis of acute supratentorial ischemia.

1 reference

12 December 2020

Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.

1 reference

12 December 2020

Effect of training in reading CT scans on patient selection for ECASS II

1 reference

12 December 2020

Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]

1 reference

12 December 2020

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1 reference

12 December 2020

Prognostic value of reperfusion during first 48 hours of ischaemic stroke.

1 reference

12 December 2020

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1 reference

12 December 2020

Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits

1 reference

12 December 2020

tPA-associated reperfusion after acute stroke demonstrated by SPECT

1 reference

12 December 2020

Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model

1 reference

12 December 2020

Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke

1 reference

12 December 2020

Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery

1 reference

12 December 2020

Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion.

1 reference

12 December 2020

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group

1 reference

12 December 2020

Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke

1 reference

12 December 2020

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

12 December 2020

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial

1 reference

12 December 2020

Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke

1 reference

12 December 2020

Is there an age limit for thrombolytic therapy?

1 reference

12 December 2020

Thresholds of focal cerebral ischemia in awake monkeys

1 reference

12 December 2020

Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice

1 reference

12 December 2020

Epidemiology of stroke

1 reference

12 December 2020

Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors

1 reference

12 December 2020

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study

1 reference

12 December 2020

Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke. Proceedings of the meeting of the SPECT Safe Thrombolysis Study Collaborators and the members of the Brain Imaging Council of the Society of Nucl

1 reference

12 December 2020

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

1 reference

12 December 2020

Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT.

1 reference

12 December 2020

Intra-arterial streptokinase in acute ischaemic stroke. A pilot study.

1 reference

12 December 2020

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

12 December 2020

THERAPEUTIC THROMBOLYSIS IN CEREBRAL THROMBOEMBOLISM. DOUBLE-BLIND EVALUATION OF INTRAVENOUS PLASMIN THERAPY IN CAROTID AND MIDDLE CEREBRAL ARTERIAL OCCLUSION

1 reference

12 December 2020

Spontaneous reperfusion of cerebral infarcts in patients with acute stroke. Incidence, time course, and clinical outcome in the Copenhagen Stroke Study

1 reference

12 December 2020

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

12 December 2020

Streptokinase increases luxury perfusion after stroke

1 reference

12 December 2020

Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anaesthetized baboons.

1 reference

12 December 2020

Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease

1 reference

12 December 2020

Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.

1 reference

12 December 2020

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Thrombolytic therapy in vertebrobasilar occlusion

1 reference

12 December 2020

Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.

1 reference

12 December 2020

Experimental thromboembolic stroke studied by positron emission tomography: immediate versus delayed reperfusion by fibrinolysis.

1 reference

12 December 2020

Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT.

1 reference

12 December 2020

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

12 December 2020

Streptokinase in acute ischaemic stroke

1 reference

12 December 2020

Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography.

1 reference

12 December 2020

Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

1 reference

12 December 2020

ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE

1 reference

12 December 2020

Thrombolysis in acute ischemic stroke: does it work?

1 reference

12 December 2020

Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model

1 reference

12 December 2020

Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats

1 reference

12 December 2020

Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)

1 reference

12 December 2020

A pilot study of streptokinase for acute cerebral infarction

1 reference

12 December 2020

Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results

1 reference

12 December 2020

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1 reference

12 December 2020

PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome.

1 reference

12 December 2020

Spontaneous reperfusion after ischemic stroke is associated with improved outcome.

1 reference

12 December 2020

Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration

1 reference

12 December 2020

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

1 reference

12 December 2020

The beneficial effect of intracarotid urokinase on acute stroke in a baboon model

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Functional recovery of cortical neurons as related to degree and duration of ischemia

1 reference

12 December 2020

Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke

1 reference

12 December 2020

Intracerebral hemorrhage after experimental embolic infarction. Anticoagulation.

1 reference

12 December 2020